Presidential Young Investigator Award

Brain & Behavior Research Foundation Awards $10.2 Million in Young Investigator Grants to 150 Mental Health Scientists

Retrieved on: 
Thursday, October 19, 2023
Brain & Behavior Research Foundation, Spectrum, Psychiatry, Psychosis, TFU, Prevalence, Pathology, Bipolar disorder, Research, Brain, OCD, PTSD, Psilocybin, Borderline personality disorder, Schizophrenia, Eating, M.D, Depression, Anxiety, Presidential Young Investigator Award, DSM-IV codes, ADHD, B cell, Pharmaceutical industry, Medical imaging, Young

A third grantee will study the application of transcranial focused ultrasound (tFUS) in such illnesses as PTSD, anxiety, and OCD.

Key Points: 
  • A third grantee will study the application of transcranial focused ultrasound (tFUS) in such illnesses as PTSD, anxiety, and OCD.
  • “BBRF Young Investigators represent a new generation of researchers who are pioneering breakthroughs in mental health research.
  • They are at the cutting edge of progress in brain and psychiatric research,” said Jeffrey Borenstein, M.D, President & CEO of the Brain & Behavior Research Foundation.
  • “BBRF Young Investigator grants have led to groundbreaking research that has improved the lives of people living with mental illness,” said Herbert Pardes, M.D., President of the BBRF Scientific Council.

The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for Its 2024 Prize for Rising Leaders in Cancer Research

Retrieved on: 
Monday, September 25, 2023
Research, Philanthropy, Biotechnology, Health, Pharmaceutical, Foundation, Other Science, Science, Oncology, Letter, Yale School of Medicine, Prize, Rockefeller University, Bone marrow, Presidential Young Investigator Award, Yale school, Doctor of Philosophy, Associate, Assistant, Biochemistry, MD, Laboratory, Weill Cornell Medicine, Biophysics, Biology, Entrepreneurship, MD–PhD, NIH, Physiology, Pharmaceutical industry, Medicine

The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2024 Pershing Square Sohn Prize for Young Investigators in Cancer Research.

Key Points: 
  • The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2024 Pershing Square Sohn Prize for Young Investigators in Cancer Research.
  • The prize of $250,000 per year for three years is awarded annually to at least six New York City area-based scientists.
  • The Prize empowers researchers to pursue novel, high-risk/high-reward cancer research at a stage when traditional funding is lacking.
  • Now providing funding and support for 66 investigators at 13 academic research institutions, the highly competitive Pershing Square Sohn Prize underwrites the bold research of cancer scientists at a formative stage in their careers.

Loliware Chief Technology Officer to Deliver Keynote at International Materials Conference

Retrieved on: 
Monday, May 15, 2023
IBM Master Inventor, IBM, California Institute of Technology, University, Doctor of Philosophy, American Chemical Society, Biotechnology, Seaweed, Creativity, Publication, Soil, Presidential Young Investigator Award, Nobel, Ecosystem, Research, SelectUSA Investment Summit, IBM Research, Aquaculture, Pharmaceutical industry

LONDON, May 15, 2023 /PRNewswire/ -- Organizers of the 2023 Rethinking Materials Innovation and Investment Summit – the premier international materials showcase – announced today that Dr. Victoria Piunova, chief technology officer of Loliware – North America's fastest-growing seaweed materials company – will give a keynote address on May 16. The annual event regularly draws industry luminaries together from around the world for educational seminars and panel discussions about the newest technological breakthroughs.

Key Points: 
  • LONDON, May 15, 2023 /PRNewswire/ -- Organizers of the 2023 Rethinking Materials Innovation and Investment Summit – the premier international materials showcase – announced today that Dr. Victoria Piunova, chief technology officer of Loliware – North America's fastest-growing seaweed materials company – will give a keynote address on May 16.
  • Founded in 2016, Loliware is a leader among a growing number of regenerative businesses focusing on materials that support a stronger ecosystem.
  • Prior to joining Loliware, Piunova spent many years at IBM Research, where she held the prestigious title of IBM Master Inventor.
  • She has more than a decade of experience in sustainable materials development for applications in biotechnology and sensing.

Loliware Chief Technology Officer to Deliver Keynote at International Materials Conference

Retrieved on: 
Monday, May 15, 2023
IBM Master Inventor, IBM, California Institute of Technology, University, Doctor of Philosophy, American Chemical Society, Biotechnology, Seaweed, Creativity, Publication, Soil, Presidential Young Investigator Award, Nobel, Ecosystem, Research, SelectUSA Investment Summit, IBM Research, Aquaculture, Pharmaceutical industry

LONDON, May 15, 2023 /PRNewswire/ -- Organizers of the 2023 Rethinking Materials Innovation and Investment Summit – the premier international materials showcase – announced today that Dr. Victoria Piunova, chief technology officer of Loliware – North America's fastest-growing seaweed materials company – will give a keynote address on May 16. The annual event regularly draws industry luminaries together from around the world for educational seminars and panel discussions about the newest technological breakthroughs.

Key Points: 
  • LONDON, May 15, 2023 /PRNewswire/ -- Organizers of the 2023 Rethinking Materials Innovation and Investment Summit – the premier international materials showcase – announced today that Dr. Victoria Piunova, chief technology officer of Loliware – North America's fastest-growing seaweed materials company – will give a keynote address on May 16.
  • Founded in 2016, Loliware is a leader among a growing number of regenerative businesses focusing on materials that support a stronger ecosystem.
  • Prior to joining Loliware, Piunova spent many years at IBM Research, where she held the prestigious title of IBM Master Inventor.
  • She has more than a decade of experience in sustainable materials development for applications in biotechnology and sensing.

An Important Step Toward International Post-Pandemic Biological Research Collaboration | CBIS 13th Biennial Meeting

Retrieved on: 
Wednesday, January 18, 2023
Disease, UCLA, Presidential Young Investigator Award, Infection, Immunity, Science, Regeneration, Communication, Institute of Biophysics, Chinese Academy of Sciences, Plant, Health, Genetics, Westlake University, Biology, Metabolism, RNA, Yale University, Systems biology, Biochemistry, Research, Cancer, Medicine, Duke University, Neuroscience, Princeton University, Pharmaceutical industry, Management

A collaboration between CBIS and Westlake University, the meeting gathered distinguished and world-renowned scientists from across all fields of life sciences under the common goal of “Enhancing and Reconnecting Biological Research in the Post-Pandemic Era”.

Key Points: 
  • A collaboration between CBIS and Westlake University, the meeting gathered distinguished and world-renowned scientists from across all fields of life sciences under the common goal of “Enhancing and Reconnecting Biological Research in the Post-Pandemic Era”.
  • The CBIS 13th Biennial Meeting facilitated an interactive platform across borders, connecting scientists and researchers to advance our fundamental understanding of biology, disease and medicine.
  • Prof. Tian Xu, chair professor of genetics and vice president of Westlake University, was one of the earliest members of CBIS.
  • With such long-lasting and meaningful connections between CBIS and Westlake University, the 13th Biennial Meeting has been a culmination of shared goals and values.

Jenny Ruiz, MD Propels Childhood Cancer Disparity Research Forward Using Children's Cancer Research Fund's (CCRF) Newly Created Award

Retrieved on: 
Thursday, January 19, 2023
Presidential Young Investigator Award, Survival rate, Philadelphia, ANC, Death, Hospital, CCRF, MD, Risk, Children's Hospital of Philadelphia, 2009 Davis Cup, Partnership, Diagnosis, Patient, Health equity, Diversity, Research, Cancer, Clinical trial, Pharmaceutical industry, Birth control, Child

MINNEAPOLIS, Jan. 19, 2023 /PRNewswire/ -- Inaugural awardee Jenny Ruiz, MD is researching barriers that may prevent childhood cancer patients with historically marginalized backgrounds from enrolling in Phase 1 clinical trials.

Key Points: 
  • MINNEAPOLIS, Jan. 19, 2023 /PRNewswire/ -- Inaugural awardee Jenny Ruiz, MD is researching barriers that may prevent childhood cancer patients with historically marginalized backgrounds from enrolling in Phase 1 clinical trials.
  • Today, racial and ethnic minority children and adolescents with cancer have a higher risk of death than non-Hispanic white children and adolescents.
  • In past decades, researchers have made incredible progress in the world of childhood cancer research and care.
  • Increase the number of doctors and researchers of color who are focused on childhood cancer research and care.

Brain & Behavior Research Foundation Awards Over $10.2 Million In Young Investigator Grants to 150 Mental Health Scientists

Retrieved on: 
Wednesday, October 12, 2022
Presidential Young Investigator Award, Method, Suicide, National Institute, Risk, Lists of diseases, Hope, Schizophrenia, National Institute of Mental Health, National Academy of Medicine, National, ADHD, Brain & Behavior Research Foundation, Foundation, Depression, Research, Borderline personality disorder, Brain, Bipolar disorder, CEO, Autism, Epidemic, National Medal, GLOBE, M.D, Anxiety, Mental health, National academy, Psychiatry, PTSD, OCD, Pharmaceutical industry, Medical device, Young

New York, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation today announced it is awarding over $10.2 million in Young Investigator Grants to 150 promising early career scientists with innovative ideas in mental health research.

Key Points: 
  • New York, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation today announced it is awarding over $10.2 million in Young Investigator Grants to 150 promising early career scientists with innovative ideas in mental health research.
  • Since 1987, the Foundation has awarded more than $440 million in research grants to more than 5,300 scientists globally.
  • BBRF Young Investigators represent a new generation of researchers who will pioneer breakthroughs in mental health research, said Jeffrey Borenstein, M.D, President & CEO of the Brain & Behavior Research Foundation.
  • The Brain & Behavior Research Foundation awards research grants to develop improved treatments, cures, and methods of prevention for mental illness.

The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for its 2023 Prize for Radically Innovative, Early-Career Cancer Researchers

Retrieved on: 
Monday, October 3, 2022
Research, Finance, Professional Services, Philanthropy, Biotechnology, Pharmaceutical, Health, Foundation, Science, Oncology, Sohn Conference Foundation, COVID, PSF, MD–PhD, Cancer, Entrepreneurship, Doctor of Philosophy, News, European Review for Medical and Pharmacological Sciences, Weill Cornell Medicine, Letter, Memorial Sloan Kettering Cancer Center, Research, Industry, Memory, Associate, Lymphatic system, Health, Economic development, MD, Alliance, Wall Street, Family, Education, Growth, Foundation, Medicine, Friends, Artificial intelligence, Partnership, Social justice, Intention, Biophysics, MT, Conference, Machine learning, Presidential Young Investigator Award, Physiology, Laboratory, DNA, Pharmaceutical industry, Prize

The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2023 Pershing Square Sohn Prize for Young Investigators in Cancer Research.

Key Points: 
  • The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2023 Pershing Square Sohn Prize for Young Investigators in Cancer Research.
  • The Prize empowers researchers to pursue novel, high-risk/high-reward cancer research at a stage when traditional funding is lacking.
  • The Pershing Square Sohn Cancer Research Alliance was formed in 2013 by The Pershing Square Foundation, which has since committed more than $35 million to 59 scientists, in partnership with The Sohn Conference Foundation.
  • Annually, the Alliance awards the Pershing Square Sohn Prize to early-career, New York area scientists who are engaged in cutting-edge cancer research.

Lung Cancer Foundation of America (LCFA) is excited to announce the appointment of Dr. Raymond Osarogiagbon to its Scientific Advisory Board

Retrieved on: 
Tuesday, March 22, 2022
Presidential Young Investigator Award, Principal, LCFA, Adult, Young, National Cancer Institute, Research, United States Air Force Scientific Advisory Board, Woman, Cancer, Lung cancer, Health, Inclusion, Equity, Time, CA, COVID-19, BCC, GLOBE, Lymph, Genetic counseling, SAB, NCI, National, Patient, Collection, Pharmaceutical industry, Uranium, Management, Facebook

Los Angeles, CA, March 22, 2022 (GLOBE NEWSWIRE) -- Lung Cancer Foundation of America (LCFA) is pleased to welcome oncologist/hematologist Dr. Raymond Osarogiagbon to its Scientific Advisory Board (SAB) .

Key Points: 
  • Los Angeles, CA, March 22, 2022 (GLOBE NEWSWIRE) -- Lung Cancer Foundation of America (LCFA) is pleased to welcome oncologist/hematologist Dr. Raymond Osarogiagbon to its Scientific Advisory Board (SAB) .
  • We are so excited to welcome Dr. Osarogiagbon to the SAB, said LCFA co-founder and president Kim Norris.
  • The Young Investigator grants help attract the best and the brightest to the field of lung cancer.
  • The goal is to fund the best research to make the largest possible positive impact for patients living with lung cancer.

Young Investigators awarded $200k to study innovative new ways to engage the body’s immune system to fight lung cancer

Retrieved on: 
Monday, January 17, 2022
Research, Patient, Treatment of lung cancer, Presidential Young Investigator Award, Mortality, CA, GLOBE, Bristol Myers Squibb, Lung cancer, Roy Castle Lung Cancer Foundation, LKB1, Immune system, Neoplasm, Immunotherapy, LCFA, Uranium, Pharma, Young

Los Angeles, CA, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Two new $200,000 grant-funded studies supported by the Lung Cancer Foundation of America, the International Lung Cancer Foundation, and generously funded in part by Bristol-Myers Squibb , are investigating ways to harness the bodys powerful immune system to better treat lung cancer.

Key Points: 
  • Los Angeles, CA, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Two new $200,000 grant-funded studies supported by the Lung Cancer Foundation of America, the International Lung Cancer Foundation, and generously funded in part by Bristol-Myers Squibb , are investigating ways to harness the bodys powerful immune system to better treat lung cancer.
  • Dr. Salehi-Rad is a lung cancer researcher studying the effects of a novel lung cancer vaccine that uses modified cells from the patients own tumor.
  • The International Lung Cancer Foundation aims to accelerate the pace of thoracic malignancy research, to inspire researchers to focus their careers on lung cancer, and to reduce the worldwide lung cancer mortality rate.
  • Lung Cancer Foundation of America is leading the fight against lung cancer through funding innovative and transformative lung cancer research.